CR11335A - Nuevas composiciones a base de taxoides - Google Patents

Nuevas composiciones a base de taxoides

Info

Publication number
CR11335A
CR11335A CR11335A CR11335A CR11335A CR 11335 A CR11335 A CR 11335A CR 11335 A CR11335 A CR 11335A CR 11335 A CR11335 A CR 11335A CR 11335 A CR11335 A CR 11335A
Authority
CR
Costa Rica
Prior art keywords
based compositions
new taxoid
taxoid
new
formulations
Prior art date
Application number
CR11335A
Other languages
English (en)
Inventor
Rortais Patricia
Gachon Carine
Original Assignee
Aventis Pharma Sa
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Sanofi Aventis filed Critical Aventis Pharma Sa
Publication of CR11335A publication Critical patent/CR11335A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)

Abstract

La presente invencion se refiere a nuevas composiciones a base de taxoides constituidas por formulaciones inyectables de estos derivados en forma de emulsion. Estas formulaciones se destinan a ser inyectadas directamente por via intravenosa.
CR11335A 2007-10-10 2010-03-24 Nuevas composiciones a base de taxoides CR11335A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0707092A FR2922107B1 (fr) 2007-10-10 2007-10-10 Nouvelles compositions a base de taxoides

Publications (1)

Publication Number Publication Date
CR11335A true CR11335A (es) 2010-08-13

Family

ID=39356621

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11335A CR11335A (es) 2007-10-10 2010-03-24 Nuevas composiciones a base de taxoides

Country Status (38)

Country Link
US (1) US8481589B2 (es)
EP (1) EP2197492B1 (es)
JP (1) JP5574965B2 (es)
KR (1) KR20100075490A (es)
CN (1) CN101820918A (es)
AR (1) AR072333A1 (es)
AT (1) ATE534406T1 (es)
AU (1) AU2008345527A1 (es)
BR (1) BRPI0818597A2 (es)
CA (1) CA2701789A1 (es)
CL (1) CL2008003002A1 (es)
CO (1) CO6260107A2 (es)
CR (1) CR11335A (es)
CY (1) CY1112388T1 (es)
DK (1) DK2197492T3 (es)
DO (1) DOP2010000098A (es)
EA (1) EA016619B1 (es)
ES (1) ES2377352T3 (es)
FR (1) FR2922107B1 (es)
GT (1) GT201000075A (es)
HR (1) HRP20120165T1 (es)
IL (1) IL204950A0 (es)
MA (1) MA31840B1 (es)
MX (1) MX2010003914A (es)
NI (1) NI201000048A (es)
NZ (1) NZ584544A (es)
PA (1) PA8798101A1 (es)
PE (1) PE20090962A1 (es)
PL (1) PL2197492T3 (es)
PT (1) PT2197492E (es)
RS (1) RS52131B (es)
SI (1) SI2197492T1 (es)
TN (1) TN2010000129A1 (es)
TW (1) TW200922552A (es)
UA (1) UA97418C2 (es)
UY (1) UY31386A1 (es)
WO (1) WO2009083664A1 (es)
ZA (1) ZA201002504B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120065255A1 (en) * 2009-10-19 2012-03-15 Nagesh Palepu Cabazitaxel formulations and methods of preparing thereof
CA2779009A1 (en) 2009-10-29 2011-05-05 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
KR101752944B1 (ko) 2010-05-03 2017-07-03 테이코쿠 팔마 유에스에이, 인코포레이티드 비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
JP2012051823A (ja) * 2010-08-31 2012-03-15 Fujifilm Corp 難容性薬物含有水中油型乳化組成物及びその製造方法
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN104225615B (zh) * 2014-09-24 2017-02-01 东南大学 一种紫杉醇类磷脂化合物、其药物组合物及应用
EP3384961B1 (en) * 2017-04-05 2021-10-13 RaySearch Laboratories AB System and method for modelling of dose calculation in radiotherapy treatment planning

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750561A (en) 1991-07-08 1998-05-12 Rhone-Poulenc Rorer, S.A. Compositions containing taxane derivatives
FR2678833B1 (fr) 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
FR2698543B1 (fr) 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US6372780B2 (en) * 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
JP2002523364A (ja) * 1998-08-20 2002-07-30 アベンテイス・フアルマ・ソシエテ・アノニム タキソイド誘導体の新規な使用
US20020001613A1 (en) * 2000-02-08 2002-01-03 Susan Niemiec Method of manufacturing liposomes
US20030099674A1 (en) 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
CN1794975A (zh) * 2003-04-29 2006-06-28 巴克斯特国际公司 使抗微生物的药物有效抗通常认为抗该药物的生物体的制剂
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
EP1498120A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid formulations for the oral administration of taxoids
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
JP5089887B2 (ja) * 2006-01-23 2012-12-05 日本精化株式会社 生理活性物質含有複合体

Also Published As

Publication number Publication date
AU2008345527A1 (en) 2009-07-09
EP2197492B1 (fr) 2011-11-23
GT201000075A (es) 2012-04-11
UA97418C2 (ru) 2012-02-10
EA016619B1 (ru) 2012-06-29
NI201000048A (es) 2010-08-20
EA201070448A1 (ru) 2010-08-30
NZ584544A (en) 2012-04-27
MA31840B1 (fr) 2010-11-01
WO2009083664A8 (fr) 2010-05-14
EP2197492A1 (fr) 2010-06-23
FR2922107A1 (fr) 2009-04-17
ATE534406T1 (de) 2011-12-15
CY1112388T1 (el) 2015-12-09
BRPI0818597A2 (pt) 2015-04-22
DOP2010000098A (es) 2010-04-30
WO2009083664A1 (fr) 2009-07-09
CN101820918A (zh) 2010-09-01
PL2197492T3 (pl) 2012-05-31
DK2197492T3 (da) 2012-03-12
US8481589B2 (en) 2013-07-09
ZA201002504B (en) 2011-06-29
PA8798101A1 (es) 2009-07-23
FR2922107B1 (fr) 2010-02-26
ES2377352T3 (es) 2012-03-26
CO6260107A2 (es) 2011-03-22
KR20100075490A (ko) 2010-07-02
US20100311825A1 (en) 2010-12-09
SI2197492T1 (sl) 2012-03-30
IL204950A0 (en) 2010-11-30
HRP20120165T1 (hr) 2012-03-31
JP2011500542A (ja) 2011-01-06
AR072333A1 (es) 2010-08-25
TW200922552A (en) 2009-06-01
CA2701789A1 (fr) 2009-07-09
PE20090962A1 (es) 2009-08-10
JP5574965B2 (ja) 2014-08-20
PT2197492E (pt) 2012-02-20
UY31386A1 (es) 2009-05-29
RS52131B (en) 2012-08-31
TN2010000129A1 (fr) 2011-09-26
CL2008003002A1 (es) 2009-10-16
MX2010003914A (es) 2010-05-17

Similar Documents

Publication Publication Date Title
CR10405A (es) Formulaciones novedosas que establizan e inhiben la precipitacion de composiciones inmunogenicas
CR11335A (es) Nuevas composiciones a base de taxoides
JOP20180102A1 (ar) مركب صيدلاني
CR11454A (es) Derivados de isoxazolo-piridina
DK2144618T3 (da) Bioeffektive krill-olie-sammensætninger
GT200800276A (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
BRPI0914375A2 (pt) ''composições antiperspirantes''
UY33469A (es) Composiciones y metodos para modular la via de señalizacion de wnt
CR11659A (es) Inhibidores de hsp90
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
MA32979B1 (fr) Derives aminoesterifies d'alcaloides et composition medicinale les incluant
GT200500126A (es) Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica
BR112015023387A2 (pt) composições lipídicas de racecodotril
HN2012001262A (es) Nuevos derivados de 8heterociclo-piperidina condensada)-( piperazinil)-1-alcanona o de (heterociclo-pirrolidina condensada)-(piperazinil)-1-alcanona y su utilizacion como inhibidores de p75
UY33282A (es) Composiciones endoparasiticidas
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
CR9211A (es) Composiciones que comprenden una epotilona y metodos de produccion
CY1112501T1 (el) Φαρμακευτικες συνθεσεις περιεχουσες λεφλουνομιδη
CR10390A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparacion, composiciones que las contienen y utilizacion
UY30368A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
UY30366A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparacion, composiciones que las contienen y utilizacion
CU20070147A7 (es) Composiciones que comprenden una epotilona y métodos para producir dicha composición

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)